Key Events This Week
2 Mar: Sharp gap down opening at Rs.400 amid market concerns
5 Mar: Valuation metrics shift from expensive to fair, signalling changing sentiment
6 Mar: Week closes at Rs.432.30, down 4.36%
Mar 20
BSE+NSE Vol: 1.73 lacs
2 Mar: Sharp gap down opening at Rs.400 amid market concerns
5 Mar: Valuation metrics shift from expensive to fair, signalling changing sentiment
6 Mar: Week closes at Rs.432.30, down 4.36%

Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Vimta Labs Ltd, a prominent player in the Healthcare Services sector, has seen its valuation metrics shift notably, moving from fair to expensive territory. Despite a recent uptick in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceed historical and peer averages, prompting a downgrade in its investment grade. This article analyses the valuation changes, compares them with sector peers, and examines the implications for investors amid the company’s mixed market performance.
Read full news article
Vimta Labs Ltd, a prominent player in the Healthcare Services sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging price performance and relative peer comparisons, prompting a downgrade in its overall rating to Sell from Hold as of 16 January 2026.
Read full news article
Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Vimta Labs Ltd, a key player in the Healthcare Services sector, opened the trading session on 2 Mar 2026 with a pronounced gap down, declining 11.5% from its previous close. This weak start reflects ongoing market apprehensions, with the stock underperforming its sector and broader indices amid sustained selling pressure.
Read full news article
Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article
Vimta Labs Ltd recorded a robust intraday performance on 9 Feb 2026, surging 7.06% to touch a day’s high of Rs 452, outperforming its sector and the broader market amid positive trading momentum.
Read full news articleVimta Labs Limited has submitted to the Exchange a copy of Related Party Transactions on consolidated basis for the half year ended September 30, 2019.
Vimta Labs Limited has informed the Exchange regarding 'Unaudited Financial Results for the second quarter and half year ended September 30, 2019, published in Financial Express (English) and Andhra Prabha (Telugu) on 11.11.2019.'.
| The Exchange has sought clarification from Vimta Labs Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Consolidated Financial Results not submitted The response of the Company is awaited. |
No Upcoming Board Meetings
Vimta Labs Ltd has declared 100% dividend, ex-date: 30 May 25
Vimta Labs Ltd has announced 2:10 stock split, ex-date: 24 Feb 06
Vimta Labs Ltd has announced 1:1 bonus issue, ex-date: 13 Jun 25
No Rights history available